TY - JOUR
T1 - Rationale, design and methodology of APPROACH-IS II
T2 - International study of patient-reported outcomes and frailty phenotyping in adults with congenital heart disease
AU - Van Bulck, Liesbet
AU - Kovacs, Adrienne H
AU - Goossens, Eva
AU - Luyckx, Koen
AU - Zaidi, Ali
AU - Wang, Jou-Kou
AU - Yadeta, Dejuma
AU - Windram, Jonathan
AU - Van De Bruaene, Alexander
AU - Thomet, Corina
AU - Thambo, Jean-Benoît
AU - Taunton, Marshall
AU - Sasikumar, Navaneetha
AU - Sandberg, Camilla
AU - Saidi, Arwa
AU - Rutz, Tobias
AU - Ortiz, Lucia
AU - Mwita, Julius Chacha
AU - Moon, Ju Ryoung
AU - Menahem, Samuel
AU - Mattsson, Eva
AU - Mandalenakis, Zacharias
AU - Mahadevan, Vaikom S
AU - Lykkeberg, Birgitte
AU - Leye, Mohamed
AU - Leong, Ming Chern
AU - Ladouceur, Magalie
AU - Ladak, Laila Akbar
AU - Kim, Yuli
AU - Khairy, Paul
AU - Kaneva, Anna
AU - Johansson, Bengt
AU - Jackson, Jamie L
AU - Giannakoulas, George
AU - Gabriel, Harald
AU - Fernandes, Susan M
AU - Enomoto, Junko
AU - Demir, Fatma
AU - de Hosson, Michèle
AU - Constantine, Andrew
AU - Coats, Louise
AU - Christersson, Christina
AU - Cedars, Ari
AU - Caruana, Maryanne
AU - Callus, Edward
AU - Brainard, Sarah
AU - Bouchardy, Judith
AU - Boer, Anna
AU - Baraona Reyes, Fernando
AU - Moons, Philip
AU - APPROACH-IS II consortium, on behalf of the International Society for Adults Congenital Heart Disease (ISACHD)
N1 - Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2022/9/15
Y1 - 2022/9/15
N2 - BACKGROUND: In recent years, patient-reported outcomes (PROs) have received increasing prominence in cardiovascular research and clinical care. An understanding of the variability and global experience of PROs in adults with congenital heart disease (CHD), however, is still lacking. Moreover, information on epidemiological characteristics and the frailty phenotype of older adults with CHD is minimal. The APPROACH-IS II study was established to address these knowledge gaps. This paper presents the design and methodology of APPROACH-IS II.METHODS/DESIGN: APPROACH-IS II is a cross-sectional global multicentric study that includes Part 1 (assessing PROs) and Part 2 (investigating the frailty phenotype of older adults). With 53 participating centers, located in 32 countries across six continents, the aim is to enroll 8000 patients with CHD. In Part 1, self-report surveys are used to collect data on PROs (e.g., quality of life, perceived health, depressive symptoms, autonomy support), and explanatory variables (e.g., social support, stigma, illness identity, empowerment). In Part 2, the cognitive functioning and frailty phenotype of older adults are measured using validated assessments.DISCUSSION: APPROACH-IS II will generate a rich dataset representing the international experience of individuals in adult CHD care. The results of this project will provide a global view of PROs and the frailty phenotype of adults with CHD and will thereby address important knowledge gaps. Undoubtedly, the project will contribute to the overarching aim of improving optimal living and care provision for adults with CHD.
AB - BACKGROUND: In recent years, patient-reported outcomes (PROs) have received increasing prominence in cardiovascular research and clinical care. An understanding of the variability and global experience of PROs in adults with congenital heart disease (CHD), however, is still lacking. Moreover, information on epidemiological characteristics and the frailty phenotype of older adults with CHD is minimal. The APPROACH-IS II study was established to address these knowledge gaps. This paper presents the design and methodology of APPROACH-IS II.METHODS/DESIGN: APPROACH-IS II is a cross-sectional global multicentric study that includes Part 1 (assessing PROs) and Part 2 (investigating the frailty phenotype of older adults). With 53 participating centers, located in 32 countries across six continents, the aim is to enroll 8000 patients with CHD. In Part 1, self-report surveys are used to collect data on PROs (e.g., quality of life, perceived health, depressive symptoms, autonomy support), and explanatory variables (e.g., social support, stigma, illness identity, empowerment). In Part 2, the cognitive functioning and frailty phenotype of older adults are measured using validated assessments.DISCUSSION: APPROACH-IS II will generate a rich dataset representing the international experience of individuals in adult CHD care. The results of this project will provide a global view of PROs and the frailty phenotype of adults with CHD and will thereby address important knowledge gaps. Undoubtedly, the project will contribute to the overarching aim of improving optimal living and care provision for adults with CHD.
KW - Cross-Sectional Studies
KW - Frailty/diagnosis
KW - Heart Defects, Congenital/diagnosis
KW - Humans
KW - Patient Reported Outcome Measures
KW - Quality of Life
KW - Frailty phenotype
KW - Congenital heart disease
KW - Patient-reported outcomes
UR - http://www.scopus.com/inward/record.url?scp=85133759448&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2022.06.064
DO - 10.1016/j.ijcard.2022.06.064
M3 - Journal article
C2 - 35780933
SN - 0167-5273
VL - 363
SP - 30
EP - 39
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -